Drug
Mk-0941 clinical trials
Also written MK-0941.
- studies test it
- 10
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
10 studies that test it; most in 2008 (4)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Studies
Open first, then newest update. How each study uses mk-0941 is read from its arms, and is right about nine times in ten.
Testing it · 10
- A Multiple Dose Investigational Drug Study in Patients With Type 2 Diabetes (MK-0941-005)CompletedPhase 1Merck Sharp & Dohme LLCNCT00511667Written as MK0941
- Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027)CompletedPhase 1Merck Sharp & Dohme LLCNCT01106287Written as MK-0941
- A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017)CompletedPhase 2Merck Sharp & Dohme LLCNCT00792935Written as MK-0941
- A Study to Test MK-0941 in Adults With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0941-018)CompletedPhase 2Merck Sharp & Dohme LLCNCT00824616Written as MK-0941
- An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin (MK-0941-006)CompletedPhase 1Merck Sharp & Dohme LLCNCT00511472Written as MK-0941
- A Study of Absorption, Metabolism, Excretion and Mass Balance After a Single Dose Administration of MK-0941 (MK-0941-016)(COMPLETED)CompletedPhase 1Merck Sharp & Dohme LLCNCT00912002Written as MK-0941
- MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).CompletedPhase 1Merck Sharp & Dohme LLCNCT00754130Written as MK-0941
- A Pharmacokinetic Study of MK-0941 After Multiple Daily Doses in Subjects With Type 2 Diabetes (MK-0941-012)(COMPLETED)CompletedPhase 1Merck Sharp & Dohme LLCNCT00873821Written as MK-0941
- A Single Dose Study to Investigate the Pharmacokinetics of MK-0941 in Participants With Renal Insufficiency (MK-0941-015-02)TerminatedPhase 1Merck Sharp & Dohme LLCNCT00830791Written as MK-0941 20 mg
- Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED)TerminatedPhase 2Merck Sharp & Dohme LLCNCT00767000Written as MK-0941
Codes
What other systems call mk-0941 · ClinicalTrials.gg INT005965
- Wikidata Q27888303mk-0941One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27888303 | mk-0941 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.